Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AK”

72 trials

Showing 20 of 72 results

Not applicableStudy completedNCT05522036
What this trial is testing

Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®

Who this might be right for
Actinic Keratoses
Centre Dermatologique du Roy 25
Not applicableStudy completedNCT03995771
What this trial is testing

Adolescent Knee Pain (AK-Pain) Prognostic Tool

Who this might be right for
Knee Pain
Aalborg University 131
Testing effectiveness (Phase 2)Study completedNCT01475955
What this trial is testing

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc. 235
Early research (Phase 1)Study completedNCT02411851
What this trial is testing

Treatment of Actinic Keratoses (AK) on the Face

Who this might be right for
Actinic Keratoses
Icahn School of Medicine at Mount Sinai 20
Large-scale testing (Phase 3)Study completedNCT03727074
What this trial is testing

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Who this might be right for
Actinic Keratosis (AK)
Sol-Gel Technologies, Ltd. 462
Post-approval studies (Phase 4)Study completedNCT03511326
What this trial is testing

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Who this might be right for
Actinic Keratoses
Galderma R&D 50
Large-scale testing (Phase 3)Study completedNCT05662202
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Who this might be right for
Actinic Keratoses
Biofrontera Inc. 172
Not applicableStudy completedNCT05260073
What this trial is testing

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Who this might be right for
Keratosis, Actinic
Almirall, S.A. 300
Large-scale testing (Phase 3)Study completedNCT02799082
What this trial is testing

Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

Who this might be right for
Actinic Keratosis
Biofrontera Bioscience GmbH 122
Large-scale testing (Phase 3)Study completedNCT00987246
What this trial is testing

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 470
Early research (Phase 1)Study completedNCT01836367
What this trial is testing

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Who this might be right for
Actinic Keratosis
Icahn School of Medicine at Mount Sinai 20
Not applicableWithdrawnNCT00814528
What this trial is testing

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Who this might be right for
Actinic Keratosis
University of Chicago
Large-scale testing (Phase 3)Study completedNCT03116698
What this trial is testing

Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period

Who this might be right for
Actinic Keratosis (AK)
Dr. Reddy's Laboratories Limited 240
Testing effectiveness (Phase 2)UnknownNCT05164393
What this trial is testing

Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK

Who this might be right for
Actinic Keratoses
Coegin Pharma AB 60
Large-scale testing (Phase 3)Study completedNCT03285477
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

Who this might be right for
Actinic Keratoses
Almirall, S.A. 351
Not applicableStudy completedNCT03202485
What this trial is testing

Comparison Between TICL and ICL+AK for High Myopic Astigmatism

Who this might be right for
AstigmatismHigh Myopia
Wenzhou Medical University 62
Testing effectiveness (Phase 2)Study completedNCT00021294
What this trial is testing

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Who this might be right for
Non-melanomatous Skin CancerPrecancerous/Nonmalignant Condition
University of Arizona
Post-approval studies (Phase 4)UnknownNCT01229319
What this trial is testing

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Who this might be right for
Actinic Keratosis
Frankel, Amylynne, M.D. 20
Post-approval studies (Phase 4)Study completedNCT02406014
What this trial is testing

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Who this might be right for
Actinic Keratosis (AK)
LEO Pharma 502
Early research (Phase 1)Looking for participantsNCT07318675
What this trial is testing

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Who this might be right for
Actinic Keratosis (AK)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation